Your browser doesn't support javascript.
loading
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
Ardini, Elena; Menichincheri, Maria; Banfi, Patrizia; Bosotti, Roberta; De Ponti, Cristina; Pulci, Romana; Ballinari, Dario; Ciomei, Marina; Texido, Gemma; Degrassi, Anna; Avanzi, Nilla; Amboldi, Nadia; Saccardo, Maria Beatrice; Casero, Daniele; Orsini, Paolo; Bandiera, Tiziano; Mologni, Luca; Anderson, David; Wei, Ge; Harris, Jason; Vernier, Jean-Michel; Li, Gang; Felder, Eduard; Donati, Daniele; Isacchi, Antonella; Pesenti, Enrico; Magnaghi, Paola; Galvani, Arturo.
Afiliación
  • Ardini E; Nerviano Medical Sciences srl, Nerviano, Milan, Italy. elena.ardini@nervianoms.com.
  • Menichincheri M; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Banfi P; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Bosotti R; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • De Ponti C; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Pulci R; Accelera srl, Nerviano, Milan, Italy.
  • Ballinari D; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Ciomei M; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Texido G; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Degrassi A; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Avanzi N; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Amboldi N; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Saccardo MB; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Casero D; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Orsini P; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Bandiera T; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Mologni L; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy.
  • Anderson D; Ignyta, Inc., San Diego, California.
  • Wei G; Ignyta, Inc., San Diego, California.
  • Harris J; Ignyta, Inc., San Diego, California.
  • Vernier JM; Ignyta, Inc., San Diego, California.
  • Li G; Ignyta, Inc., San Diego, California.
  • Felder E; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Donati D; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Isacchi A; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Pesenti E; Accelera srl, Nerviano, Milan, Italy.
  • Magnaghi P; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
  • Galvani A; Nerviano Medical Sciences srl, Nerviano, Milan, Italy.
Mol Cancer Ther ; 15(4): 628-39, 2016 04.
Article en En | MEDLINE | ID: mdl-26939704
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_colon_rectum_cancers / 6_congenital_chromosomal_anomalies Asunto principal: Benzamidas / Inhibidores de Proteínas Quinasas / Indazoles / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2016 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_colon_rectum_cancers / 6_congenital_chromosomal_anomalies Asunto principal: Benzamidas / Inhibidores de Proteínas Quinasas / Indazoles / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2016 Tipo del documento: Article País de afiliación: Italia